Strategies Evolve for B-Cell Depletion in Lupus Nephritis
Growing evidence suggests more complete B-cell depletion in patients with lupus nephritis is associated with a greater likelihood of treatment response.
Stay updated with breaking news from Ar T. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Growing evidence suggests more complete B-cell depletion in patients with lupus nephritis is associated with a greater likelihood of treatment response.
CAR T-cell therapy showed efficacy in achieving complete responses among patients with relapsed or refractory CLL or SLL after BTKi and BCL2 inhibitor.
NEW YORK, June 09, 2023 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company...
Dublin, June 06, 2023 (GLOBE NEWSWIRE) -- The "Global and China Passenger Car T-Box Market Report, 2023" report has been added to ...
The CAR T-cell construct was associated with significantly better progression-free survival than standard-of-care multidrug regimens.